Home › Degenerasyon ng Macula › Illinois
Pag-aaral pangklinika para sa Degenerasyon ng Macula sa Illinois
13 pag-aaral para sa Degenerasyon ng Macula ang naghahanap ng mga kalahok sa mga site sa Illinois.
Mga Lungsod sa Illinois
Opisyal na teksto ng pag-aaral (English)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- University Retina, Lemont
Nagre-recruitPhase 2/3
Edad 60 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06635148A Study in Adults With Geographic Atrophy
- University Retina and Macula Associates, P.C., Lemont
Nagre-recruitPhase 2
Edad 60 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07606365A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Illinois Retina Associates, Oak Park
- Springfield Clinic, Springfield
Nagre-recruitPhase 2/3
Edad 50 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07440225A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- University of Illinois at Chicago, Chicago
- Retinal Vitreal Consultants, Chicago
- The University of Chicago, Chicago
- at 3 pa
Nagre-recruitPhase 3
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Northwestern Medical Group, Chicago
- The University of Chicago Medicine Duchossois Center for Advanced Medicine, Chicago
- Retina Associates, Ltd., Elmhurst
- at 1 pa
Nagre-recruitPhase 2
Edad 55 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06659445A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- University Retina and Macula Associates, Oak Forest
Nagre-recruitObservasyonal na pag-aaral
Edad 55 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07144137A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- University Retina and Macula Associates, Oak Forest
Nagre-recruitPhase 1
Edad 50 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT03178149Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- University Retina & Macula Associates, Lemont
Nagre-recruit
Edad 60 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Illinois Chicago - UI Health, Chicago
Nagre-recruitObservasyonal na pag-aaral
Edad 6 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- University Retina and Macula Associates, Oak Forest
Nagre-recruitPhase 1/2
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Illinois Retina Associates, Joliet
- University Retina & Macula Associates, P.C., Lemont
Nagre-recruitPhase 2/3
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07496567Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 179, Lemont
Nagre-recruitPhase 2
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07630649Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Retina Associates, Ltd., Elmhurst
- University Retina and Macula Associates, PC, Oak Forest
- Illinois Retina Associates, Oak Park
- at 1 pa
Nagre-recruitPhase 3
Edad 50 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07064759Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.